Y-mAbs Therapeutics
YMAB
#8247
Rank
NZ$0.31 B
Marketcap
$6.87
Share price
-0.90%
Change (1 day)
-73.35%
Change (1 year)

EPS for Y-mAbs Therapeutics (YMAB)

EPS in 2023 (TTM): -$1.52

According to Y-mAbs Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.49. In 2022 the company made an earnings per share (EPS) of -$3.66 a decrease over its 2021 EPS that were of -$2.08.

EPS history for Y-mAbs Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.52-58.44%
2022-$3.6675.81%
2021-$2.08-58.25%
2020-$4.9828.57%
2019-$3.8867.32%
2018-$2.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.66 144.94%๐Ÿ‡บ๐Ÿ‡ธ USA